Guo Chen
About
In The Last Decade
Guo Chen
103 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 121
- Molecular Biology 779
- Cancer Research 412
- Surgery 280
- Pulmonary and Respiratory Medicine 204
- Oncology 185
Countries citing papers authored by Guo Chen
This map shows the geographic impact of Guo Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guo Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guo Chen more than expected).
Fields of papers citing papers by Guo Chen
This network shows the impact of papers produced by Guo Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guo Chen. The network helps show where Guo Chen may publish in the future.
Co-authorship network of co-authors of Guo Chen
This figure shows the co-authorship network connecting the top 25 collaborators of Guo Chen. A scholar is included among the top collaborators of Guo Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guo Chen. Guo Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 11 | |
| 6 | 3 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 2 | |
| 11 | 19 | |
| 12 | 31 | |
| 13 | Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma | 1 |
| 14 | Chrysophanol Inhibits the Progression of Diabetic Nephropathy via Inactivation of TGF-β Pathway | 1 |
| 15 | Knockdown of lncRNA MCM3AP-AS1 Attenuates Chemoresistance of Burkitt Lymphoma to Doxorubicin Treatment via Targeting the miR-15a/EIF4E Axis | 1 |
| 16 | 8 | |
| 17 | LncRNA NNT-AS1 affect progesterone resistance by regulating miR-542-3p/survivin axis in endometrial cancer | 3 |
| 18 | Salidroside ameliorates autophagy and activation of hepatic stellate cells in mice via NF-κB and TGF-β1/Smad3 pathways | 2 |
| 19 | Nanovector-based prolyl hydroxylase domain 2 silencing system enhances the efficiency of stem cell transplantation for infarcted myocardium repair | 1 |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.